Refine by
Infection Test Articles & Analysis: Older
28 news found
International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. ...
MRSA can spread to people who touch a contaminated surface and cause infections if it gets into a cut, scrape, or open wound. In the past, most MRSA infections have been associated with hospitalization or other healthcare-associated risk factors. ...
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. Despite progress, an effective animal model that mimics human immune response during HIV/TB co-infection has been lacking, hindering treatment and vaccine development. Bohorguez et al. ...
This occurs when people nearby breathe in the bacteria and then become infected. This is why transmission can be a significant risk in healthcare environments and other places where many people share the same space for extended periods of time. ...
The checkerboard test is an experimental method used to evaluate the interaction of two antimicrobial test compounds. In this test, the MIC and MBC values of the test compounds are used individually and combined with the MIC and MBC values of each bacterial strain being evaluated to calculate accumulation. ...
However, sometimes it can cause infections ranging from minor skin infections to serious infections that can be fatal in some circumstances. ...
More than 2.8 million antibiotic-resistant infections occur in the U.S. each year and more than 35,000 people die as a result according to the CDC’s 2019 Antibiotic Resistance (AR) Threats Report. ...
Liaison Memed Bv is an immune system based protein signature test for distinguishing between bacterial and viral infections The test was developed following the licensing agreement signed with Memed as announced in September 2020 The new test is available on the Liaison Xl platforms in countries that accept CE mark and U.S. ...
ByMeMed
The study demonstrated the test’s high performance in distinguishing between bacterial and viral infection Incorporated a broad pediatric population presenting with fever without source and respiratory tract infection MeMed’s test outperformed existing biomarkers of infection MeMed, a leader in ...
ByMeMed
The new funding will be used for continued development and clinical studies to support FDA clearance of the ViraBac EZTM test, which reads gene expression patterns in the immune system to identify whether a suspected infection is bacterial or viral. ...
The company is developing other host-response diagnostic tests that identify the presence and type of infection (viral or bacterial) and predict the risk of severe disease, which could enable physicians to make more informed decisions for patients with acute infection and sepsis. All tests will run on the company’s ...
Abnormalities in pulmonary function tests infection have been described. The determinants of these abnormalities are still unclear. 38 subjects were included in the study. ...
ByFluidda
Have your employees tested regularly! With this new test you will be reliably informed about possible COVID-19 infections in your company. ...
Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. ...
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced the availability of three over-the-counter COVID-19 testing options in stores and online. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection ...
” “This is an important stage of Inflammatix’s growth as the company advances its first product – the InSep acute infection and sepsis test – towards commercialization and continues development of its deep pipeline. I am excited to join Tim and our talented team as we unleash the power of immune-response testing to ...
The company’s tests can identify the presence and type of infection (viral or bacterial), and the risk of severe disease, including severe COVID-19, to enable physicians to make more informed decisions. ...
It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection. “The CE Marking of the OSOM® Ultra Plus Flu A&B Test expands our flu portfolio allowing us to provide a more accurate rapid influenza ...
Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, to further develop its point-of-care test and system to diagnose infection by reading the immune system. The contract is part of a BARDA contract worth up to $72 million, if all options are exercised. ...
Kephera Diagnostics announced today that it has been awarded a two-year, $1,989,300 Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), to complete the development and launch of a new test for Zika virus infection. Kephera’s ...